A Phase 1b/2 Randomized Phase 2 Study Evaluating the Efficacy of Doxorubicin With or Without a Human Anti-PDGFRa Monoclonal Antibody (IMC-3G3) in the Treatment of Advanced Soft Tissue Sarcoma

Objective

Not available at this time

IRB Protocol Number

10-1261

Principal Investigator(s)

ANTHONY ELIAS

Cancer Trials

• Sarcoma

Sponsor(s)

ImClone Systems, Inc.

Contact

TESSA MCSPADDEN at 720-848-0609
or TESSA.MCSPADDEN@UCDENVER.EDU

Eligibility and Other Participant Information

What To Expect : Not available at this time // Not available at this time